Study of the Membrane Activity of the Synthetic Peptide ∆M3 Against Extended-Spectrum β-lactamase Escherichia coli Isolates
- PMID: 38315239
- PMCID: PMC11006780
- DOI: 10.1007/s00232-024-00306-3
Study of the Membrane Activity of the Synthetic Peptide ∆M3 Against Extended-Spectrum β-lactamase Escherichia coli Isolates
Abstract
Escherichia coli is the most common microorganism causing nosocomial or community-acquired bacteremia, and extended-spectrum β-lactamase-producing Escherichia coli isolates are identified worldwide with increasing frequency. For this reason, it is necessary to evaluate potential new molecules like antimicrobial peptides. They are recognized for their biological potential which makes them promising candidates in the fight against infections. The goal of this research was to evaluate the potential of the synthetic peptide ΔM3 on several extended-spectrum β-lactamase producing E. coli isolates. The antimicrobial and cytotoxic activity of the peptide was spectrophotometrically determined. Additionally, the capacity of the peptide to interact with the bacterial membrane was monitored by fluorescence microscopy and infrared spectroscopy. The results demonstrated that the synthetic peptide is active against Escherichia coli isolates at concentrations similar to Meropenem. On the other hand, no cytotoxic effect was observed in HaCaT keratinocyte cells even at 10 times the minimal inhibitory concentration. Microscopy results showed a permeabilizing effect of the peptide on the bacteria. The infrared results showed that ΔM3 showed affinity for the lipids of the microorganism's membrane. The results suggest that the ∆M3 interacts with the negatively charged lipids from the E. coli by a disturbing effect on membrane. Finally, the secondary structure experiments of the peptide showed a random structure in solution that did not change during the interaction with the membranes.
Keywords: Antimicrobial peptides; Antimicrobial resistance; Extended-spectrum β-lactamase-producing in Escherichia coli; Fluorescence microscopy; Infrared spectroscopy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
[Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].Mikrobiyol Bul. 2015 Jan;49(1):15-25. doi: 10.5578/mb.8437. Mikrobiyol Bul. 2015. PMID: 25706727 Turkish.
-
Community-Acquired Uropathogenic Escherichia coli, Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection.MEDICC Rev. 2022 May 16;24(2):20-25. doi: 10.37757/mr2022.v24.n2.2. MEDICC Rev. 2022. PMID: 35648059
-
Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.Appl Environ Microbiol. 2020 Jul 20;86(15):e00742-20. doi: 10.1128/AEM.00742-20. Print 2020 Jul 20. Appl Environ Microbiol. 2020. PMID: 32471914 Free PMC article.
-
In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7. Microbiol Spectr. 2021. PMID: 34232101 Free PMC article. Clinical Trial.
-
[Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli].Rinsho Shinkeigaku. 2012;52(1):12-8. doi: 10.5692/clinicalneurol.52.12. Rinsho Shinkeigaku. 2012. PMID: 22260973 Review. Japanese.
References
-
- Bezabih YM, Bezabih A, Dion M, Batard E, Teka S, Obole A, Dessalegn N, Enyew A, Roujeinikova A, Alamneh E. Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC-Antimicrob Res. 2022;4:dlac048. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical